Literature DB >> 10026782

Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons.

H Gainer1.   

Abstract

The oxytocin (OT) and vasopressin (VP) expressing magnocellular neurons in the hypothalamic-neurohypophysial system (HNS) have been the most studied of all the neuroendocrine cell-types. Despite this, our understanding of the mechanisms that underly the cell-specific expression of the peptide genes in these neurons has remained obscure. Part of the reason for this may be related to the close apposition of the OT and VP genes in the chromosomal locus, the genes being separated by as little as 3.5 kb in the mouse, and their interactions which are critical for cell-specific expression of the genes. Recent studies using intact rat OT and VP constructs in transgenic mice, and rat and mouse VP genes with CAT inserts in exon III as reporters in transgenic rats and mice, respectively, have suggested the presence of cell-specific enhancer elements in the 3' downstream (intergenic region, IGR) region of the VP gene. Evidence in favor of this view is presented from transgenic mouse studies on the expression of mouse OT- and VP-CAT gene constructs. Oxytocin and vasopressin phenotypes in the magnocellular neuronal population have traditionally been assessed by either immunocytochemical or in situ hybridization histochemical methods leading to the view that these genes are never coexpressed. However, more sensitive methods show that most OT cells also express some VP mRNA, and most VP cells contain some OT mRNA. A third phenotype containing equivalent levels of both OT and VP mRNA can also be found under some conditions, thereby complicating our analysis of cell-specificity. A continuing problem hindering studies of the regulation of OT and VP gene expression in neurons, is the absence of an appropriate cell line to examine these issues. We have found that stationary slice-explant cultures allow for excellent preservation of highly differentiated magnocellular neurons in long-term culture, and that these cultures can be used for physiological and pharmacological studies and analysis of gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10026782     DOI: 10.1007/978-1-4615-4871-3_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Developmental regulation of a local positive autocontrol of supraoptic neurons.

Authors:  V Chevaleyre; G Dayanithi; F C Moos; M G Desarmenien
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 2.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

3.  Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo.

Authors:  Raymond L Fields; Todd A Ponzio; Makoto Kawasaki; Harold Gainer
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 4.  Oxytocin Modulation of Neural Circuits.

Authors:  Mariela Mitre; Jessica Minder; Egzona X Morina; Moses V Chao; Robert C Froemke
Journal:  Curr Top Behav Neurosci       Date:  2018

5.  Oxytocin receptor signaling contributes to olfactory avoidance behavior induced by an unpleasant odorant.

Authors:  Kazumi Osada; Tohru Ohta; Rie Takai; Sadaharu Miyazono; Makoto Kashiwayanagi; Shizu Hidema; Katsuhiko Nishimori
Journal:  Biol Open       Date:  2018-09-26       Impact factor: 2.422

Review 6.  Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin.

Authors:  Maria Antonietta Panaro; Tarek Benameur; Chiara Porro
Journal:  J Clin Med       Date:  2020-05-19       Impact factor: 4.241

7.  Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species.

Authors:  Markus Muttenthaler; Åsa Andersson; Irina Vetter; Rohit Menon; Marta Busnelli; Lotten Ragnarsson; Christian Bergmayr; Sarah Arrowsmith; Jennifer R Deuis; Han Sheng Chiu; Nathan J Palpant; Margaret O'Brien; Terry J Smith; Susan Wray; Inga D Neumann; Christian W Gruber; Richard J Lewis; Paul F Alewood
Journal:  Sci Signal       Date:  2017-12-05       Impact factor: 8.192

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.